tert-Butyl 6,6-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate

Catalog No. :
ACSYCC225
CAS No. :
2222867-19-6
Molecular Formula :
C22H39B2NO6
Molecular Weight :
435.18

IUPAC Name:tert-butyl 6,6-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate

tert-Butyl 6,6-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$330.00Login to see priceInquiryInquiry
100mg98%$484.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 6,6-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate
IUPAC Nametert-butyl 6,6-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate
Molecular FormulaC22H39B2NO6
Molecular Weight435.18
SMILESO=C(N1CC2C(B3OC(C)(C)C(C)(C)O3)(B4OC(C)(C)C(C)(C)O4)C2C1)OC(C)(C)C
InChI KeyPACTWBBVCHFKON-UHFFFAOYSA-N
Synonym3-Azabicyclo[3.1.0]hexane-3-carboxylic acid, 6,6-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, 1,1-dimethylethyl ester
CAS No.2222867-19-6

Synthetic Route by SureRoute

1. ACSYCC225 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUNTP062 route compound structure diagram
    ACUNTP0622853484-52-1 In Stock
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACSYCC225 route product structure diagram
    ACSYCC2252222867-19-6
Inquiry

2. ACSYCC225 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACSYCC225 route product structure diagram
    ACSYCC2252222867-19-6
Inquiry

Comments (0)